Inhibition of testosterone biosynthesis by ethanol: relation to the pregnenolone-to-testosterone pathway  by Eriksson, C.J.P. et al.
Volume 172, number 2 FEBS 1578 July 1984 
Inhibition of testosterone biosynthesis by ethanol: relation to the 
pregnenolone-to-testosterone pathway 
C.J.P. Eriksson, T.V. Widenius, P. Leinonen*, M. HBrkiinen+ and R.H. Ylikahri 
Research Laboratories of the Finnish State Alcohol Company, Alko Ltd, POB 350, SF-00101 Helsinki IO, 
*Department of Clinical Chemistry, University of Oulu, SF-90220 Oulu 22 and +Department of Clinical Chemistry, 
University of Helsinki, SF-00290 Helsinki 29, Finland 
Received 26 April 1984 
The concentrations of metabolites in the pregnenolone -+ testosterone pathway were determined in freeze- 
stopped testes in control rats and during ethanol intoxication (2 h after injection of 1.5 g ethanol/kg body 
wt). Ethanol lowered the mean testicular concentrations of testosterone (by 63-74%), androstenedione 
(49-81%), 17-hydroxyprogesterone (60-76%), progesterone (29-67%) and pregnenolone (12-25%). 
4-Methylpyrazole had no effect on the ethanol-induced changes. The present results reveal no inhibition 
at the 17-hydroxyprogesterone - androstenedione --+ testosterone steps, but do not exclude inhibition 
before the step yielding pregnenolone and at the pregnenolone - progesterone - 
17-hydroxyprogesterone steps. 
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1. INTRODUCTION 
The biosynthesis of testosterone in rat testis in- 
volves the following pathway: cholesterol + 
pregnenolone ---+ progesterone + 17a-hydroxy- 
progesterone - androstenedione --+ testosterone 
[l]. Any of these steps may, in principle, be the 
target for the ethanol-mediated inhibition of 
testosterone production, a well-documented effect 
in rats [2-l 11. Inhibition of pregnenolone forma- 
tion is supported by observations [2,12,13] after 
ethanol treatment of lowered testosterone levels 
associated with decreased levels of luteinizing hor- 
mone (LH), the primary gonadotropin regulating 
testicular conversion of cholesterol to pregnenol- 
one [14]. The generality may, however, be ques- 
tioned, because no changes were found in mice [ 151 
and increased LH levels were found in humans 
116,171 under conditions in which ethanol de- 
creased the plasma testosterone levels. The oxida- 
tive, NAD+-dependent, transformation of pregne- 
nolone to progesterone, requiring 3&hydroxy- 
steroid dehydrogenase (EC 1.1.1.51) [l], could 
also be the target for the ethanol-mediated inhibi- 
tion. This possibility is indirectly supported by 
observations that ethanol competitively inhibited 
NAD+-dependent retinol oxidation in testis homo- 
genates [181 and excess NAD+ reversed ethanol-in- 
duced inhibition of testosterone synthesis in 
isolated lysed Leydig cells [5], and by the fact that 
NAD+-dependent ethanol oxidation has been 
detected in rat testis [ 11,19,20]. Moreover, chronic 
ethanol treatment seems to reduce the NAD+ 
availability of 3&hydroxysteroid dehydrogenase 
[21]. The inhibitory role of the NAD+ deficiency 
is, however, questioned in a recent investigation 
reporting no changes in testicular NAD+ after 
ethanol treatment in vivo or in vitro [22]. That the 
inhibition would take place after progesterone for- 
mation has also been suggested [lo]. Based on the 
inhibition of 17a-hydroxyprogesterone aldolase 
(EC 4.1.2.30), cleavage of 17cu-hydroxyprogester- 
one to androstenedione has been proposed as the 
target for the ethanol effect [23]. Inhibition, under 
in vitro conditions, has also been observed at the 
last step of testosterone biosynthesis, the NADPH- 
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dependent reduction of androstenedione to testos- 
terone [B]. According to the proposed mechanism, 
ethanol-derived acetaldehyde directly inhibits 17p- 
hydroxysteroid dehydrogenase (EC 1.1.1.64). 
However, it was recently demonstrated that on 
stimulation by human chorionic gonadotropin 
(hCG) in vivo the inhibition probably occurs 
before the pregnenolone - progesterone step, in 
contrast to the situation in vitro with the inhibited 
androstenedione --+ testosterone step [9]. 
The inhibitory effects of ethanol on hCG- 
stimulated testosterone biosynthesis have been 
found in both in vitro and in vivo studies to be 
blocked by alcohol dehydrogenase (EC 1.1.1.1) in- 
hibitors [4,24,25]. This suggests that ethanol per se 
is not responsible for the inhibition and that it is 
instead produced by some factors arising from 
ethanol metabolism, such as competition for 
NAD+ at the pregnenolone -+ progesterone step 
or acetaldehyde-mediated inhibition of the an- 
drostenedione -+ testosterone step. Both of these 
possibilities were, however, contradicted by recent 
findings under nonstimulated in vivo conditions 
[ 111. In fact, an ethanol-induced decrease in the 
3-hydroxybutyrate/acetoacetate ratio, indicating a 
decreased free NADH/free NAD+ ratio, seemed to 
be associated with inhibited testosterone produc- 
tion. 
Here, the localization of the inhibitory step(s) 
was studied in a nonstimulated in vivo situation by 
determination of the concentrations of testoster- 
one and its steroid precursors in testis with direct 
freeze-stop techniques. 
2. MATERIALS AND METHODS 
2.1. Rats 
Male Long-Evans rats, 2.5-3.5 months old, 
bred in our laboratory (originating from rats pur- 
chased from Simonsen, Gilroy, CA), were used in 
the experiments. The animals were given a stan- 
dard laboratory diet (Astra-Ewos AB, Sodertalje, 
Sweden) and water ad libitum. 
2.2. General procedures 
All experiments were performed between 08.00 
and 11.00 h. In the first series of experiments 
animals were divided into 4 groups: a control 
group that received no injections, an ethanol group 
injected intraperitoneally with 1.5 g ethanol/kg 
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body wt as a 10% (w/v) solution in 0.9% NaCI, a 
4-methylpyrazole + ethanol group injected in- 
traperitoneally with 10 mg 4-methylpyrazole/kg 
body wt (Labkemi AB, Gothenburg, Sweden) as a 
0.1% (w/v) solution in 0.9% NaCl 30 min before 
the 1.5 g ethanol/kg injection, and a 4-methylpy- 
razole group which received 10 mg 4-methylpyra- 
zole/kg but no ethanol. In the second series of ex- 
periments animals were divided into two groups: 
the control group (no treatment) and ethanol 
group (1.5 g/kg). Tail-blood samples were taken 
2 h after ethanol administration. Immediately 
after tail-blood sampling rats were cervically 
dislocated and one of the testes was (within 30 s) 
excised and freeze-stopped by rapid immersion in 
liquid Nz, An additional blood sample was taken 
by decapitation. 
Tail blood was hemolysed with ice-cold water. 
The hemolysates were used directly for ethanol 
analyses (mean concentrations between 22 and 
33 mM as previously reported) [l 11. Blood taken 
after decapitation was centrifuged at 800 x g for 
15 min at 4°C. Plasma was removed and stored at 
- 17°C for 4-5 weeks before testosterone analysis. 
The frozen testes were stored for 6-7 weeks at 
- 70°C before testosterone and precursor analysis. 
2.3. Analytical procedures 
Head-space gas chromatography with a Perkin- 
Elmer F40 instrument was applied for the deter- 
mination of ethanol [26]. 
Plasma testosterone was measured as in [27], 
with a radioimmunoassay kit supplied by Nor- 
diclab (Oulu). 
Testicular steroid concentrations were measured 
as in [28]. Briefly, testis pieces (about 100 mg) 
were homogenized in water on ice and steroids 
were extracted with diethyl ether/ethyl acetate. 
The organic phases were chromatographed on l-ml 
Lipidex-5000 columns, and steroids were quan- 
titated from the appropriate fractions by a specific 
radioimmunoassay system [29]. The recovery was 
monitored by inclusion of 3H-labeled steroid in 
each sample, and samples with recovery of less 
than 85% were re-analysed. Hence no correction 
for recovery was needed. The inter-assay coeffi- 
cients of variation for steroid assays were 
monitored by inclusion of a known serum sample 
in each series of 15 testis samples, and were below 
13%. 
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2.4. Statistical analyses 
The results are given as means j, SD. Group 
mean comparisons were made with Student’s t- 
distribution [30]. Pearson r coefficients [31] were 
used for correlation analyses. 
3. RESULTS 
3.1. Effects of ethanol on the pregnenolone -+ 
testosterone path way 
In the first series of experiments the ethanol 
group showed markedly decreased testicular 
testosterone 0) < O.Ol), 17-hydroxyprogesterone 
@ < 0.05) and progesterone @ < 0.05) concentra- 
tions relative to controls (table 1). 
4-Methylpyrazole treatment did not prevent the 
ethanol-induced decreases; in fact, the statistical 
results were even more significant and androstene- 
dione was now significantly lowered as well @ < 
0.0005). No significant effects were observed 
regarding the pregnenolone concentrations. 
4-Methylpyrazole treatment alone had no effects, 
and the 4-methylpyrazole results were combined 
with those of the corresponding control and 
ethanol for some of the subsequent analyses. To 
examine further the possibility of ethanol in- 
hibiting any of the steps from pregnenolone to 
testosterone, the product/substrate ratios of this 
pathway were calculated. The control ratios from 
combined control and 4-methylpyrazole groups 
were as follows: progesterone/pregnenolone = 
2.04 + 0.92; 17-hydroxyprogesterone/progester- 
one = 2.54 + 0.96; androstenedione/l7-hydroxy- 
progesterone = 0.40 + 0.15; testosterone/andros- 
tenedione = 6.82 + 2.63. The ethanol ratios from 
combined ethanol and 4-methylpyrazole + ethanol 
groups and their probabilities relative to the con- 
trols were as follows: progesterone/pregnenolone 
= 1.20 + 0.66 @ < 0.01); 17-hydroxyprogester- 
one/progesterone = 1.81 + 0.92 @ < 0.05); an- 
drostenedione/l7-hydroxyprogesterone = 0.48 f 
0.22 (not significant, n.s.); testosterone/andros- 
tenedione = 6.88 -+ 4.11 (n.s.). 
With a view to the fact that the pregneno- 
lone --+ testosterone metabolites have not pre- 
viously been determined in a nonstimulated situa- 
tion during ethanol oxidation, and to the relatively 
large variability in the first results, another series 
of experiments was conducted on another genera- 
tion of Long-Evans rats. The 4-methylpyrazole 
groups were omitted because of the obvious lack of 
effect on the ethanol-induced inhibition of ste- 
roidogenesis. On the other hand, dehydroepian- 
drosterone and plasma testosterone were now also 
determined. In accordance with the earlier ex- 
periments (table l), ethanol reduced the levels of 
17-hydroxyprogesterone, androstenedione and 
testosterone (table 2). A reduction was also seen in 
the dehydroepiandrosterone and plasma testoster- 
one concentrations. The decrease observed pre- 
viously in progesterone concentrations was not 
significant in our experiments, perhaps due to the 
Table 1 
Effects of ethanol and 4-methylpyrazole on the pregnenolone -+ testosterone pathway 
Metabolite Metabolite concentration (pmol/g wet wt) 
Control 
(n = 9) 
Control + 
4-methyl- 
pyrazole 
(n = 8) 
Ethanol 
(n = 10) 
Ethanol + 
4-methyl- 
pyrazole 
(n = 10) 
Pregnenolone 52 & 38 41 + 21 46 + 30 35 f 22 
Progesterone 87 & 52 126 + 49 43 + 27a 42 + 25’ 
17-Hydroxyprogesterone 246 f 213 283 f 143 75 + 5oa 67 + 47’ 
Androstenedione 89 + 66 125 + 58 45+ 31 24 f 11’ 
Testosterone 590 f 350 693 rt 207 217 + 149b 181 + 109’ 
Values are means f SD from freeze-stopped testes. Samples were taken after cervical dislocation 
2 h after ethanol (1.5 g/kg body wt) and 2.5 h after 4-methylpyrazole (10 mg/kg body wt) 
injections. Compared with corresponding control group, a p < 0.05, b p < 0.01, = p < o.ooo5 
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relatively low IeveIs and high variability, but a 
decrease in the pregnenolone concentration was 
now found. 
The following product/substrate ratios were ob- 
tained in the second series of experiments for the 
control group: progesterone/pregnenolone = 
0.58 + 0.36; 17-hydroxyprogesterone/progester- 
one = 3.63 +_ 1.81; androstenedione/i7-hydroxy- 
progesterone = 3.67 +_ 3.09; testosterone/andro- 
stenedione = 2.66 +_ 0.95. The corresponding 
ratios (and probabilities relative to the control 
group) obtained for the ethanol group were: pro- 
gesterone/pregnenolone = 0.60 -C 0.28 (n.s.); 
17-hydroxyprogesterone/progesterone = 1.97 k 
0.80 @ c 0.001); androstenedione/l7-hydroxypro- 
gesterone = 2.46 + 2.17 (n.s.); testosterone/ 
androstenedione = 3.09 -+ 1.37 (n.s.). No dif- 
ferences were observed in the testis/plasma 
testosterone ratio: controls = 9.0 f 7.3; ethanol 
rats = 8.1 + 2.5. 
Table 3 lists individual correlations within the 
pregnenolone - testosterone pathway from both 
series of experiments. The purpose of the correla- 
Table 2 
Effects of ethanol on the pregnenoione - testosterone 
pathway 
Metabolite Metabolite concen- 
tration (pmol/ml 
or g wet wt) 
Control Ethanol 
(n = 29) (n = 30) 
PIasma 
Testosterone 13.4 f 8.1 7.1 + 5.0a 
(n = 16) (n = 17) 
Testis 
Pregnenolone 40 + 24 30 + 14a 
Progesterone 24 + 24 17 f 10 
17-Hydroxy- 
progesterone 81 +- 83 32 -t 19b 
Dehydroepi- 
androsterone 5.3 f 3.7 3.6 + 2.7a 
Androstenedione 181 & 118 63 f 41’ 
Testosterone 432 + 261 159 f 72’ 
Values are means + SD from freeze-stopped testes. 
Samples were taken after cervical dislocation 2 h after 
ethanol (1.5 g/kg body wt) injections. Compared with 
the control group, a p < 0.06, b p < 0.005, ’ p < 0.001 
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tion analysis was to obtain further information 
about the site(s) of ethanol inhibition of 
steroidogenesis. For example, if ethanol acts 
primarily at a particular single step, one could ex- 
pect that the presumed positive correlation bet- 
ween substrate and product in the control group 
might be disturbed by ethanol and could even be 
made negative at that step. However, as 
demonstrated in table 3, this was not the case. 
Regardless of ethanol treatment, the correlation 
between substrate and product concentration 
seemed high in the single steps. In addition, the 
low correlation in both the control and ethanol 
groups between dehydroepiandrosterone and other 
steroids (except androstenedione) could be noted. 
4. DISCUSSION 
4.1. Biosynthesis of testosterone from 
pregnenolone: effects of ethanol 
It has been suggested that the major route for 
testicular steroidogenesis involves the 4-ene 
pathway, i.e., pregnenolone --t progesterone - 
17-hydroxyprogesterone - androstenedione - 
testosterone, in rats, and the 5-ene route, i.e., 
pregnenolone - 17-hydroxypregnenolone --+ 
dehydroepiandrosterone --+ androstenedione (or 
androstenediol) -+ testosterone, in humans [l]. 
The normal testicular concentrations of the 
steroids in these pathways (table 1,2) have not been 
determined in vivo in rats. The present results, 
showing very low dehydroepiandrosterone concen- 
trations and the absence of correlations between 
this steroid and pregnenolone, or testosterone, are 
in line with the earlier view regarding the 4-ene 
pathway. The positive correlation between 
dehydroepiandrosterone and androstenedione con- 
centration, and the general pattern of the correla- 
tions with dehydroepiandrosterone - positive cor- 
relations with other steroids within the 5-ene 
pathway and negative correlations with steroids in 
the 4-ene pathway that are not in the 5-ene one - 
(table 3) suggest, however, that the 5-ene pathway 
occurs in rats and may play a minor role in 
steroidogenesis. The fact that pregnenolone, pro- 
gesterone, 17-hydroxyprogesterone and andros- 
tenedione all correlated positively with testoster- 
one suggests that steroidogenesis involves regula- 
tory, rate-limiting sites before these steroids. 
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Table 3 
Interrelations in the pregnenolone -+ testosterone pathway 
Pregnen- 
olone 
Proges- 
terone 
17-Hydroxy- 
progesterone 
Dehydro- 
epiandros- 
terone 
Andros- 
tene- 
dione 
Testos- 
terone 
Progesterone 
Control 1 
Control 2 
Ethanol 1 
Ethanol 2 
331 
703c 
658b 
390a 
17-Hydroxyprogesterone 
Control 1 497= 
Control 2 814’ 
Ethanol 1 705b 
Ethanol 2 502b 
Dehydroepiandrosterone 
Control 2 061 
Ethanol 2 136 
Androstenedione 
Control 1 
Control 2 
Ethanol 1 
Ethanol 2 
253 
559b 
178 
462= 
Testosterone 
Control 1 
Control 2 
Ethanol 1 
Ethanol 2 
327 
385a 
754c 
408a 
Testosterone (plasma) 
Control 2 439 
Ethanol 2 125 
817’ 
899’ 
807’ 
784’ 
- 270 
- 365” 
777c 903c 
263 447= 
411 670b 
076 441= 
708b 
293 
579= 
215 
621= 
- 121 
- 160 
-213 
720b 
490= 
886c 
613’ 
840’ 
374 
452a 
719b 
804’ 333 
564a 
831’ 188 
744b 072 580a 
563” 155 688b 
The matrix of individual correlations is shown. Values are product-moment correlation coefficients (X 10’). Control 
1 (i.e., control and 4-methylpyrazole groups combined after normalization) and ethanol 1 (i.e., ethanol and 
4-methylpyrazole + ethanol groups combined after normalization) refer to the experiments listed in table 1. Control 
2 and ethanol 2 refer to the experiments listed in table 2. a p < 0.05, b p c 0.005, ’ p < 0.0005 
The large standard deviations and the dif- 
ferences between the controls in table 1,2 are to be 
expected, because the animals of the Long-Evans 
strains are genetically heterogenous and two dif- 
ferent generations were used. We believe it 
strengthens the significance of our finding that a 
clear ethanol effect on testosterone, androstene- 
dione and 17-hydroxyprogesterone can be seen in 
spite of the large basic biological variation. 
Our results contradict some earlier suggestions 
based on in vitro studies. Thus, the view that the 
inhibitory action of ethanol may be mediated by 
acetaldehyde inhibiting the androstenedione - 
testosterone step [8] seems unlikely, based on the 
present experiments in which ethanol lowered both 
these levels similarly in vivo (table 1,2). This con- 
firms similar conclusions reached in a recent in- 
vestigation using hCG-stimulated in vivo condi- 
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tions [9]. On the same basis, it seems that the step 
from 17-hydroxyprogesterone to androstenedione 
[23] could also be eliminated as a primary site for 
the ethanol-induced inhibition of steroidogenesis. 
An inhibitory influence on the progesterone ----+ 
17-hydroxyprogesterone step may be possible, as 
suggested by the product/substrate ratios of the 
values listed in table 1,2. In addition, the data 
listed in table 1 support inhibition at the 
pregnenolone ---+ progesterone step, while this ef- 
fect was not prominent in the second series of ex- 
periments (table 2). Inhibition before pregneno- 
lone cannot be excluded, as is clearly demonstrated 
in table 2. Thus in conclusion, the present steroid 
concentration results supports inhibitory actions 
before pregnenolone, and at the pregnenolone --+ 
progesterone and progesterone--+ 17-hydroxypro- 
gesterone steps, but not at the 17-hydroxyproges- 
terone - androstenedione and androstenedione 
- testosterone steps. 
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